Testosterone levels in men begin declining around age 30, at approximately 1-2% per year. By the time most men are in their 40s, the cumulative decline is clinically meaningful — not necessarily diagnostic by standard criteria, but often sufficient to produce symptoms in men who were previously at higher-normal levels.
The problem is that "low testosterone" is defined in population terms — the lower portion of the distribution in a reference population. But reference ranges include men who are symptomatic at their current level. A man whose testosterone in his 30s was 900 ng/dL and is now 380 ng/dL has lost more than half his functional testosterone — but 380 falls within the broad "normal" reference range of most labs.
The difference between normal and optimal
Total testosterone reference ranges in most labs span from roughly 270 to 1070 ng/dL. This range captures the 2.5th to 97.5th percentile of a reference population. A value of 280 ng/dL is "normal" by this definition. So is 1000 ng/dL. They are not remotely equivalent in their physiological effect.
The relevant question is not "is my testosterone in the normal range?" It is "is my testosterone appropriate for my age, my symptoms, and my functional goals?" This reframe is the difference between an age-adjusted functional approach and a population-average reference approach.
What low testosterone actually feels like
The symptom cluster of testosterone deficiency in men is consistent and clinically recognizable:
Fatigue that is pervasive rather than situational — present throughout the day, not explained by inadequate sleep. Reduced motivation and drive — described by patients as a loss of the competitive edge or initiative they previously had. Difficulty maintaining lean mass and increased abdominal fat despite consistent exercise. Reduced libido and sometimes erectile dysfunction or reduced erectile quality. Mood changes — specifically, flattened affect, reduced optimism, and lower tolerance for frustration. Cognitive slowing — particularly reduced verbal fluency and processing speed. Sleep disruption.
This symptom cluster is not specific to testosterone deficiency — it overlaps with depression, hypothyroidism, sleep apnea, and other conditions. Lab work distinguishes them.
Low testosterone in your 40s is not just 'getting older.'
The Hormone Health Assessment identifies symptom patterns consistent with testosterone deficiency and clarifies whether a clinical evaluation makes sense.
Take the AssessmentTotal testosterone vs. free testosterone vs. SHBG
The most commonly ordered test — total testosterone — measures bound and unbound testosterone together. But testosterone's biological activity depends on the free (unbound) fraction. SHBG (sex hormone-binding globulin) is the primary binding protein; as SHBG rises with age, free testosterone can be clinically low even when total testosterone appears adequate.
A complete testosterone evaluation includes total testosterone, free testosterone (calculated or direct), SHBG, LH and FSH (to distinguish primary from secondary hypogonadism), estradiol (testosterone converts to estrogen via aromatase; elevated estradiol in men requires clinical attention), and hematocrit and PSA as baseline safety markers.
A testosterone evaluation based on total testosterone alone misses meaningful clinical information.
When does testosterone deficiency require treatment?
The clinical threshold for treatment is not a lab number — it is the intersection of symptoms and lab values. A patient with a total testosterone of 280 ng/dL and no symptoms may not benefit from treatment. A patient with a total testosterone of 400 ng/dL with significant symptoms and appropriately elevated SHBG may be meaningfully functionally deficient.
The clinical decision integrates symptoms, labs, clinical history, and patient goals. Testosterone optimization at Revitalize begins with this comprehensive evaluation — not a single number.
What treatment actually involves
Testosterone replacement therapy at Revitalize is delivered via Biote pellet therapy: small pellets inserted subcutaneously that release testosterone steadily over three to five months. This avoids the peaks and troughs of injection therapy and the skin-transfer risk of topical gels.
Monitoring follows initiation: labs at three to six months to verify appropriate levels and check hematocrit, PSA, and estradiol. Annual labs thereafter. Most men notice early changes in energy and mood within two to four weeks. Libido typically improves within four to six weeks. Body composition changes take three to six months of sustained optimization.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.